01 2Alliance revenue - Adempas/Verquvo
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2022 Revenue in Millions : 341
2021 Revenue in Millions : 342
Growth (%) : -0.3
Main Therapeutic Indication : Cardiology/Vascular Diseases
Currency : USD
2023 Revenue in Millions : 367
2022 Revenue in Millions : 341
Growth (%) : 7.6
LOOKING FOR A SUPPLIER?